Severe thrombocytopaenia secondary to COVID-19

The SARS-CoV-2 infection has caused a pandemic with a case rate of over 290 000 lab-confirmed cases and over 40 000 deaths in the UK. There is little evidence to inform the optimal management of a patient presenting with new or relapsed acute idiopathic thrombocytopaenic purpura with concurrent SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Trupesh, Stanton, Noah, Gkikas, Ioannis, Triantafyllopoulou, Diana Ioanna Dionysia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
New Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493096/
https://www.ncbi.nlm.nih.gov/pubmed/32933915
http://dx.doi.org/10.1136/bcr-2020-237645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493096/
https://www.ncbi.nlm.nih.gov/pubmed/32933915
http://dx.doi.org/10.1136/bcr-2020-237645

Ejemplares similares